These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38400046)

  • 21. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain.
    Halvorson T; Ivison S; Huang Q; Ladua G; Yotis DM; Mannar D; Subramaniam S; Ferreira VH; Kumar D; Belga S; Levings MK;
    Transplantation; 2024 Apr; 108(4):e49-e62. PubMed ID: 38012843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Karaba AH; Zhou W; Li S; Aytenfisu TY; Johnston TS; Akinde O; Eby Y; Abedon AT; Alejo JL; Qin CX; Thompson EA; Garonzik-Wang JM; Blankson JN; Cox AL; Bailey JR; Klein SL; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Clin Infect Dis; 2023 Feb; 76(3):e495-e498. PubMed ID: 35959783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave.
    Al Jurdi A; Morena L; Cote M; Bethea E; Azzi J; Riella LV
    Am J Transplant; 2022 Dec; 22(12):3130-3136. PubMed ID: 35727916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ.
    Dharia A; Boulet J; Sridhar VS; Kitchlu A
    Transplantation; 2022 Jan; 106(1):e64-e65. PubMed ID: 33795594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant.
    Serper M; Liu CH; Blumberg EA; Burdzy AE; Veasey S; Halpern S; Lander E; Sigafus MR; Bloom RD; Dunn TB; Abt PL; Reddy KR; Mehta SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13722. PubMed ID: 34496115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls.
    Søfteland JM; Gisslén M; Liljeqvist JÅ; Friman V; de Coursey E; Karason K; Ekelund J; Felldin M; Magnusson J; Baid-Agrawal S; Wallquist C; Schult A; Jacobsson H; Bergdahl A; Bemark M; Andersson LM; Holm Gunnarsson I; Stenström J; Leach S
    Am J Transplant; 2022 Apr; 22(4):1245-1252. PubMed ID: 34860447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of COVID-19 in solid organ transplant recipients: A matched cohort study.
    Pereira MR; Arcasoy S; Farr MA; Mohan S; Emond JC; Tsapepas DS; Shi Q; Purpura L; Uhlemann AC; Zucker J; Verna EC
    Transpl Infect Dis; 2021 Aug; 23(4):e13637. PubMed ID: 33993630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
    Cheng JY; Li FY; Ko CJ; Colegio OR
    JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Mortality Among Recipients of Solid-Organ Transplantation in Ontario, Canada.
    Acuna SA; Fernandes KA; Daly C; Hicks LK; Sutradhar R; Kim SJ; Baxter NN
    JAMA Oncol; 2016 Apr; 2(4):463-9. PubMed ID: 26746479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Mortality of Emergency General Surgery Conditions Among Solid Organ Transplant Recipients in Ontario, Canada: A Population-based Analysis.
    Gomez D; Acuna SA; Joseph Kim S; Nantais J; Santiago R; Calzavara A; Saskin R; Baxter NN
    Transplantation; 2023 Mar; 107(3):753-761. PubMed ID: 36117253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population.
    Vinson AJ; Anzalone A; Schissel M; Dai R; French ET; Olex AL; Mannon RB;
    Am J Transplant; 2023 Jul; 23(7):1035-1047. PubMed ID: 37105315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients.
    Karaba AH; Zhu X; Liang T; Wang KH; Rittenhouse AG; Akinde O; Eby Y; Ruff JE; Blankson JN; Abedon AT; Alejo JL; Cox AL; Bailey JR; Thompson EA; Klein SL; Warren DS; Garonzik-Wang JM; Boyarsky BJ; Sitaras I; Pekosz A; Segev DL; Tobian AAR; Werbel WA
    Am J Transplant; 2022 Apr; 22(4):1253-1260. PubMed ID: 34951746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies.
    Tang Y; Li Y; Song T
    Front Immunol; 2023; 14():1150341. PubMed ID: 37081880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.
    Chiang TP; Alejo JL; Mitchell J; Kim JD; Abedon AT; Karaba AH; Thomas L; Levan ML; Garonzik-Wang JM; Avery RK; Pekosz A; Clarke WA; Warren DS; Tobian AAR; Massie AB; Segev DL; Werbel WA
    Am J Transplant; 2022 Sep; 22(9):2254-2260. PubMed ID: 35429211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.
    Heldman MR; Kates OS; Safa K; Kotton CN; Georgia SJ; Steinbrink JM; Alexander BD; Hemmersbach-Miller M; Blumberg EA; Crespo MM; Multani A; Lewis AV; Eugene Beaird O; Haydel B; La Hoz RM; Moni L; Condor Y; Flores S; Munoz CG; Guitierrez J; Diaz EI; Diaz D; Vianna R; Guerra G; Loebe M; Rakita RM; Malinis M; Azar MM; Hemmige V; McCort ME; Chaudhry ZS; Singh P; Hughes K; Velioglu A; Yabu JM; Morillis JA; Mehta SA; Tanna SD; Ison MG; Tomic R; Candace Derenge A; van Duin D; Maximin A; Gilbert C; Goldman JD; Sehgal S; Weisshaar D; Girgis RE; Nelson J; Lease ED; Limaye AP; Fisher CE;
    Am J Transplant; 2021 Aug; 21(8):2774-2784. PubMed ID: 34008917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world Evidence of COVID-19 Vaccines Effectiveness in Solid-organ Transplant Recipient Population in Colombia: A Study Nested in the Esperanza Cohort.
    Pinto-Álvarez M; Fernández-Niño JA; Arregocés-Castillo L; Rojas-Botero ML; Palacios AF; Galvis-Pedraza M; Ruiz-Gomez F
    Transplantation; 2023 Jan; 107(1):216-224. PubMed ID: 36228269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients.
    Ferreira VH; Marinelli T; Ierullo M; Ku T; Hall VG; Majchrzak-Kita B; Kulasingam V; Humar A; Kumar D
    J Infect Dis; 2021 Dec; 224(11):1849-1860. PubMed ID: 34739078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
    Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
    Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.